Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs

Journal of Clinical Investigation

Volumn 121, Issue 9, 2011, Pages 3713-3723

  Ramnanan, Christopher J ^a   Saraswathi, Viswanathan ^a   Smith, Marta S ^a   Donahue, E Patrick ^a   Farmer, Ben ^a   Farmer, Tiffany D ^a   Neal, Doss ^a   Williams, Philip E ^a   Lautz, Margaret ^a   Mari, Andrea ^b   Cherrington, Alan D ^a   Edgerton, Dale S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; DOG; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLYCOGEN LIVER LEVEL; GLYCOGEN SYNTHESIS; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOTHALAMUS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN; DOGS; FATTY ACIDS, NONESTERIFIED; GLUCAGON; GLUCONEOGENESIS; GLUCOSE; GLYCOGEN; HUMANS; HYPERINSULINISM; INSULIN; LIVER;

EID: 80052345224     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI45472     Document Type: Article

References (41)

1. Cherrington A.D. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes. 1999;48(5):1198-1214. (Pubitemid 29226371)
2. Woods S.C., Porte D. Jr. Neural control of the endocrine pancreas. Physiol Rev. 1974;54(3):596-619.
3. Chen M., Woods S.C., Porte D. Jr. Effect of cerebral intraventricular insulin on pancreatic insulin secretion in the dog. Diabetes. 1975;24(10):910-914.
4. Paranjape S.A., et al. Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo. Diabetes. 2010;59(6):1521-1527.
5. Obici S., Zhang B.B., Karkanias G., Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med. 2002; 8(12):1376-1382. (Pubitemid 36019422)
6. Lam T.K., et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med. 2005;11(3):320-327. (Pubitemid 40460561)
7. Pocai A., Obici S., Schwartz G.J., Rossetti L. A brainliver circuit regulates glucose homeostasis. Cell Metab. 2005;1(1):53-61. (Pubitemid 43960581)
8. German J., et al. Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology. 2009;150(10):4502-4511.
9. Inoue H., et al. Role of hepatic STAT3 in braininsulin action on hepatic glucose production. Cell Metab. 2006;3(4):267-275.
10. Lam T.K., Gutierrez-Juarez R., Pocai A., Rossetti L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science. 2005;309(5736):943-947. (Pubitemid 41099933)
11. Okamoto H., Obici S., Accili D., Rossetti L. Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest. 2005;115(5):1314-1322. (Pubitemid 40629051)
12. Pocai A., et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature. 2005; 434(7036):1026-1031.
13. Konner A.C., et al. Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab. 2007;5(6):438-449. (Pubitemid 46825497)
14. Sandoval D.A., Obici S., Seeley R.J. Targeting the CNS to treat type 2 diabetes. Nat Rev Drug Discov. 2009; 8(5):386-398.
15. Ono H. The hypothalamus bridges the gap between physiology and biochemistry in high-fat diet-induced hepatic insulin resistance. Cell Cycle. 2009;8(18):2885-2887.
16. Park S., Hong S.M., Ahn I.S. Long-term intracerebroventricular infusion of insulin, but not glucose, modulates body weight and hepatic insulin sensitivity by modifying the hypothalamic insulin signaling pathway in type 2 diabetic rats. Neuroendocrinology. 2009;89(4):387-399.
17. Perseghin G., et al. Regulation of glucose homeostasis in humans with denervated livers. J Clin Invest. 1997; 100(4):931-941. (Pubitemid 27371712)
18. Moore M.C., Satake S., Baranowski B., Hsieh P.S., Neal D.W., Cherrington A.D. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am J Physiol Endocrinol Metab. 2002; 282(2):E286-E296. (Pubitemid 34654798)
19. Sindelar D.K., Balcom J.H., Chu C.A., Neal D.W., Cherrington A.D. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes. 1996;45(11):1594-1604. (Pubitemid 26357554)
20. Edgerton D.S., et al. Insulin's direct effects on the liver dominate the control of hepatic glucose production. J Clin Invest. 2006;116(2):521-527. (Pubitemid 43228370)
21. Havrankova J., Roth J., Brownstein M.J. Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents. J Clin Invest. 1979;64(2):636-642. (Pubitemid 9235011)
22. Bergman R.N. New concepts in extracellular signaling for insulin action: The single gateway hypothesis. Recent Prog Horm Res. 1997;52:359-385. (Pubitemid 127470217)
23. Mittelman S.D., Fu Y.Y., Rebrin K., Steil G., Bergman R.N. Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J Clin Invest. 1997; 100(12):3121-3130. (Pubitemid 28022850)
24. Sindelar D.K., Chu C.A., Rohlie M., Neal D.W., Swift L.L., Cherrington A.D. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes. 1997;46(2):187-196. (Pubitemid 27272250)
25. Ramnanan C.J., et al. Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo. Diabetes. 2010;59(6):1302-1311.
26. Moore M.C., et al. Disposition of a mixed meal by the conscious dog. Am J Physiol. 1994; 266(4 pt 1):E666-E675.
27. Bishop J.S., Larner J. Rapid activation-inactivation of liver uridine diphosphate glucose-glycogen transferase and phosphorylase by insulin and glucagon in vivo. J Biol Chem. 1967;242(6):1354-1356.
28. Moh A., et al. STAT3 sensitizes insulin signaling by negatively regulating glycogen synthase kinase-3 beta. Diabetes. 2008;57(5):1227-1235.
29. Scherer T., et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab. 2011;13(2):183-194.
30. Burgess S.C., et al. Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab. 2007;5(4):313-320. (Pubitemid 46477858)
31. Cherrington A.D., Moore M.C., Sindelar D.K., Edgerton D.S. Insulin action on the liver in vivo. Biochem Soc Trans. 2007;35(pt 5):1171-1174. (Pubitemid 350206454)
32. Kokubun E., Hirabara S.M., Fiamoncini J., Curi R., Haebisch H. Changes of glycogen content in liver, skeletal muscle, and heart from fasted rats. Cell Biochem Funct. 2009;27(7):488-495.
33. Hendrick G.K., Frizzell R.T., Williams P.E., Cherrington A.D. Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast. Am J Physiol. 1990;258(5 pt 1):E841-E849. (Pubitemid 20179446)
34. Nuttall F.Q., Ngo A., Gannon M.C. Regulation of hepatic glucose production and the role of gluconeogenesis in humans: Is the rate of gluconeogenesis constant? Diabetes Metab Res Rev. 2008; 24(6):438-458.
35. Strowski M.Z., Blake A.D. Function and expression of somatostatin receptors of the endocrine pancreas. Mol Cell Endocrinol. 2008;286(1-2):169-179.
36. Brand C.L., et al. Role of glucagon in maintenance of euglycemia in fed and fasted rats. Am J Physiol. 1995; 269(3 pt 1):E469-E477.
37. Cherrington A.D., Chiasson J.L., Liljenquist J.E., Lacy W.W., Park C.R. Control of hepatic glucose output by glucagon and insulin in the intact dog. Biochem Soc Symp. 1978;(43):31-45. (Pubitemid 9134364)
38. Liljenquist J.E., et al. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. J Clin Invest. 1977; 59(2):369-374. (Pubitemid 8055697)
39. Javaheri S., Corbett W. Ethanol is a potent inhibitor of canine cerebrospinal fluid production: An acute and reversible effect. Brain Res. 1998;812(1-2):91-96. (Pubitemid 29005335)
40. Burgess S.C., et al. Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase. J Biol Chem. 2004; 279(47):48941-48949. (Pubitemid 39625775)
41. Mari A., Stojanovska L., Proietto J., Thorburn A.W. A circulatory model for calculating non-steady-state glucose fluxes. Validation and comparison with compartmental models. Comput Methods Programs Biomed. 2003;71(3):269-281. (Pubitemid 36683227)